Subscribe

Biocompounding

Biocompounding

Ascendis Pharma (ASND): Redefining Drug Delivery with TransCon

Introduction Ascendis Pharma is a biopharmaceutical company applying its TransCon technology to develop a pipeline of long-acting prodrug therapies with best-in-class profiles to address large markets with significant unmet medical needs. The company was founded in 2007 and is headquartered in Copenhagen, Denmark, with offices in the United States. The

Halozyme Therapeutics (HALO): Bets on Licensing Model to Drive Growth

Halozyme Therapeutics (HALO): Bets on Licensing Model to Drive Growth

Introduction Halozyme Therapeutics is a biotechnology company that was co-founded in 1998 by Dr. Gregory Frost and subsequently listed in 2014. Halozyme’s focus was on oncology therapies and drug delivery technologies based on its proprietary recombinant human hyaluronidase enzyme, rHuPH20, but following the failure of its oncology drug, the

GLP-1 Drugs: Not a Miracle Cure for Weight Loss

GLP-1 Drugs: Not a Miracle Cure for Weight Loss

Weight loss drugs have been the talk of the town for the last couple of months. The weight loss drugs on the market are Wegovy, Ozempic from Novo Norodisk (NVO), and Mounjaro from Eli Lilly (LLY). You can read our deep dive on Novo Nordisk here. These drugs consist of

Intuitive Surgical

Intuitive Surgical (ISRG) Deep Dive

Introduction Intuitive Surgical is a company that specializes in robotic surgical systems. These systems allow surgeons to perform many procedures with the assistance of highly advanced robotic arms, that allow for designed for minimally invasive, soft tissue procedures. Minimally invasive surgery (MIS) is a type of surgery that is performed

An Overview of CAR-T Cell Therapy And a New Manufacturing Method

An Overview of CAR-T Cell Therapy And a New Manufacturing Method

Understanding CAR-T Cell therapy and a look at a new manufacturing method that can revolutionize the industry

Danaher Corporation (DHR) brands

Danaher Corporation (DHR) Valuation Exercise

Danaher Corporation (DHR) reported earnings for the first quarter on 25th April. The report came in below guidance, resulting in the share price dropping. Here are Biocompounding, we have been waiting for a pullback in Biotech picks & shovels plays to establish our position. Following the report, we went through a

The race to sequence the world - A look at Next Generation Sequencing (NGS)

The race to sequence the world - A look at Next Generation Sequencing (NGS)